Appropriate Antibiotic Dosage Levels in the Treatment of Severe Sepsis and Septic Shock
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Appropriate Antibiotic Dosage Levels in the Treatment of Severe Sepsis and Septic Shock
Authors
Keywords
-
Journal
Current Infectious Disease Reports
Volume 13, Issue 5, Pages 406-415
Publisher
Springer Nature
Online
2011-07-29
DOI
10.1007/s11908-011-0203-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic drug monitoring of vancomycin in severe sepsis and septic shock
- (2011) M. Vázquez et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Augmented Creatinine Clearance in Traumatic Brain Injury
- (2010) Andrew Udy et al. ANESTHESIA AND ANALGESIA
- Amikacin Monotherapy for Sepsis Caused by Panresistant Pseudomonas aeruginosa
- (2010) B. Layeux et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Obesity on the Pharmacokinetics of Drugs in Humans
- (2010) Michael J. Hanley et al. CLINICAL PHARMACOKINETICS
- Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept
- (2010) Jason A. Roberts et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A higher dose of vancomycin in continuous infusion is needed in critically ill patients
- (2010) A. Jeurissen et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Recent changes in vancomycin use in renal failure
- (2010) Stefaan J. Vandecasteele et al. KIDNEY INTERNATIONAL
- Prospectively Validated Dosing Nomograms for Maximizing the Pharmacodynamics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients
- (2009) F. Pea et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Continuous Infusion of Vancomycin Less Effective and Safe than Intermittent Infusion, Based on Pharmacodynamic and Pharmacokinetic Principles
- (2009) Prachant Nannan Panday et al. CLINICAL INFECTIOUS DISEASES
- Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health‐System Pharmacists, and the Society of Infectious Diseases Pharmacists
- (2009) Michael J. Rybak et al. CLINICAL INFECTIOUS DISEASES
- Should the Currently Recommended Twice-Daily Dosing Still be Considered the Most Appropriate Regimen for Treating MRSA Ventilator-Associated Pneumonia with Vancomycin?
- (2009) Federico Pea et al. CLINICAL PHARMACOKINETICS
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
- (2009) R Phillip Dellinger et al. CRITICAL CARE MEDICINE
- Pharmacokinetic issues for antibiotics in the critically ill patient
- (2009) Jason A. Roberts et al. CRITICAL CARE MEDICINE
- Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit*
- (2009) Andrew F. Shorr CRITICAL CARE MEDICINE
- Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy
- (2009) Paul R. Ingram et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis
- (2009) Jason A. Roberts et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Vancomycin Dosing for Pneumonia in Critically Ill Trauma Patients
- (2009) Asad E. Patanwala et al. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
- Delay of Active Antimicrobial Therapy and Mortality among Patients with Bacteremia: Impact of Severe Neutropenia
- (2008) M. Y. Lin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Postantibiotic and Post-Beta-Lactamase Inhibitor Effect of Carbapenems Combined with EDTA against Pseudomonas aeruginosa Strains Producing VIM-Metallo Beta-Lactamases
- (2008) B. Bedenić et al. CHEMOTHERAPY
- Outcomes of Bacteremia due to Pseudomonas aeruginosa with Reduced Susceptibility to Piperacillin-Tazobactam: Implications on the Appropriateness of the Resistance Breakpoint
- (2008) V. H. Tam et al. CLINICAL INFECTIOUS DISEASES
- Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections
- (2008) Peggy S. McKinnon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Suboptimal Aminoglycoside Dosing in Critically Ill Patients
- (2008) Rhonda S Rea et al. THERAPEUTIC DRUG MONITORING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now